Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens

Debbie Kuo, MD

Status

Not yet enrolling

Conditions

Epi-retinal Membrane

Cataract and IOL Surgery

Treatments

Procedure: retinal surgery

Device: cataract surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT07070492

2025.067-1

Details and patient eligibility

About

To investigate the patient Quality of Life and satisfaction outcomes of combined cataract surgery with retinal surgery for visually significant epiretinal membrane in patients receiving Vivity IOL versus standard monofocal controls.

Full description

The information gained by this study will help understand better the suitability of Vivity IOLs for patients with a common retinal condition and potentially expand access and offering of premium IOLs to help patients gain independence from glasses, which can improve quality of life.

Enrollment

36 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult patients with visually significant epiretinal membrane who are undergoing or have already had pars plana vitrectomy and membrane peel combined with cataract surgery using Clareon Vivity and Clareon Vivity Toric IOLs or monofocal IOL
IOL powers between +6D to +30.0D, T3-T6

Exclusion criteria

History of ocular or refractive surgery
Other ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity, such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, strabismus/amblyopia etc.
Patients with irregular astigmatism, corneal dystrophies, pupil abnormalities, zonular laxity
Intraoperative or postoperative complications